IMT Feedback

    Did the IMT help you in finding the resource you needed?

    Your feedback helps us improve the toolkit in the future.

    Are you experiencing difficulties? Please include information on your search query and used browser



    Input this code: captcha

    Skip to content
    ERDERA IMT

    AstraZeneca Open Innovation

    Categories

    • Funding
      • Private
        • Foundations
        • Loans
        • Grant
        • Fellowship
        • Venture Capital/Angel Investment
        • Incubators/Accelerators
        • Awards
        • Crowdfunding
      • Public
        • Incubators/Accelerators
        • Fellowship
        • Awards
        • Grant
        • Loans
    • Translational Project Management
      • Technology Transfer Offices (TTOs)
        • What is technology transfer?
        • TTO and Intellectual Property management
        • TTO and Commercialisation
      • Project Management
        • Data Management
        • Project Management Manual
      • TPP
      • Reverse Planning Approach
      • Consulting & Advice
        • TREAT-NMD Advisory Committee for Therapeutics (TACT)
    • Research and Drug Development
      • Disease Model
        • In silico
        • Cell Model
        • Animal Model
      • Disease or Translational Resources
        • Patient registries
        • Data Bases and Tools
        • Natural History
        • Patients Information
        • Target Patient Value Profile
        • Networks
        • Biobanks
        • Biomarkers
      • Drug Discovery
        • Small Molecules
        • Advanced Therapies
        • Target Validation
        • High Throughput Screening (HTS)
        • Bioassays
        • Drug Repurposing
      • Data Collection
        • Patient Registries
      • Clinical Development
        • Safety Reporting
        • Clinical Trial Design
        • Endpoints
        • Patients
    • Regulatory Science
      • Biologicals
      • Early access support
        • Nan-byo designation
        • Orphan medicines
        • Medical Devices
        • Scientific Advice
        • Orphan drug designation
        • SME Office
        • Paediatric medicines
        • Advanced Therapy
        • Patient Advice
        • Scientific guidelines
      • Preclinical Studies
        • Efficacy
      • Clinical Development
        • Endpoints
        • Good Clinical Practices
        • Compassionate Use
      • Marketing Authorisation
        • FDA Priority Review Vaucher (PRV)
        • EU Marketing Authorisation Road Map
        • Orphan Medicines Procedure
        • Advanced Therapy procedure
        • Paediatric Medicines Procedure
        • Conditional Approval
        • Exceptional Circumstances
        • Accelerated Assessment
      • Ethic and Legal Issues
        • Data protection and confidentiality
        • Clinical Studies
        • Clinical Trials
        • Orphan medicines
        • Genetics
        • Paediatrics
        • Advanced Therapies
        • Animal Welfare
      • HTA
        • National HTA Bodies
        • European HTA Bodies
        • International HTA Bodies
    • Intellectual Property
      • Basics of Intellectual Property
        • Types of Intellectual Property
        • Intellectual Property Teaching Kit
        • European IP Helpdesk
        • Freedom to Operate (FTO)
      • Patent Filing
        • International Patent Cooperation Treaty (PCT) Route
        • European Route
        • American Route
      • Patent Search
        • Patentscope
        • Espacenet
      • Market Exclusivity
        • Incentives in Orphan Medicines
        • Incentives in Paediatric Medicines
      • Commercialisation

    Subjects

    All SubjectsPreclinical ResearchClinical ResearchBasic ResearchIndustrial Development or SMEPrivateGrantPublicVenture Capital or Angel InvestmentAwardFellowshipAccelerator or IncubatorFoundationPreclinical ReasearchIndustrial Devolpment or SMEInsustrial Development or SMEInternationalNational (UK)FellowshipsFellowshipsGrantIncubator/Acceleretor

    Regions

    • All regions
      • International
      • Europe

    ASTRA ZENECA

    1. Showing 1 result for:
    2. ASTRA ZENECA
    All SubjectsBasic Research

    AstraZeneca Open Innovation

    Published by ASTRA ZENECA

    Basic ResearchClinical ResearchIndustrial Development or SMEPreclinical ResearchPrivate

    Collaboration opportunities

    View this resource Bookmark this resource
    The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575. The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.
    © 2026 ERDERA IMT | GetYos IT